Report Id: PMDDM1119
Marine Derived Drugs Market Size By Type (Phenol, Steroid, Ether, Peptide), By Source (Algae, Microorganisms, Invertebrates), By Application (Anti-microbial, Anti-viral, Anti-inflammatory, Anti-tumor, Anti-cardiovascular, Other), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
The Global Marine Derived Drugs Market is expected to be around US$ 3565 Million by 2028 at a CAGR of 9.1% in the given forecast period.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HERENorth America
9
South America
5
Europe
8
APAC
10
Others
7
MARKET SNAPSHOT
Major Players
- Abbott Laboratories
- BioMarin Pharmaceutical Inc.
- GlaxoSmithKline Plc
- Marine Polymer Technologies
- Pharma Marine USA
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
9
REPORT DESCRIPTION
The Global Marine Derived Drugs Market is expected to be around US$ 3565 Million by 2028 at a CAGR of 9.1% in the given forecast period.
The world is full of natural resources and the large part of the worlds most popular drugs are directly or indirectly derived from these natural resources. Marine biosphere is the biggest one of the earth and harbors a gigantic number of various life forms. Living conditions vary in a general sense from those in earthbound condition. The creation of explicit auxiliary metabolites is a significant adaption component of marine living beings to get by in the ocean. These metabolites have biological activities which make them fascinating as potential medications for human.
The rise in the adoption of marine-derived drugs in the treatment of tumors causing infections is driving the growth of marine-derived drugs market around the world. They are likewise inconceivably being utilized in the treatment of tuberculosis, malaria, osteoporosis, infectious diseases and HIV. Moreover, the presentation of new screening innovation and developing an investigation of marine condition exercises are significantly adding to the growth of marine-derived drugs market globally.
The global Marine Derived Drugs market is segregated on the basis of Type as Phenol, Steroid, Ether, Peptide, and Others. Based on Source the global Marine Derived Drugs market is segmented in Algae, Microorganisms, and Invertebrates. Based on Application the global Marine Derived Drugs market is segmented in Anti-microbial, Anti-viral, Anti-inflammatory, Anti-tumor, Anti-cardiovascular, and Other.
The global Marine Derived Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Marine Derived Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Abbott Laboratories, BioMarin Pharmaceutical, Inc., GlaxoSmithKline Plc, Marine Polymer Technologies, Pharma Marine USA, Genzyme, Bayer Innovation, Takeda Oncology’s Millennium, Xenome Limited, Pfizer, and others are among the major players in the global Marine Derived Drugs market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Marine Derived Drugs Market has been segmented as below:
Marine Derived Drugs Market, By Type
- Phenol
- Steroid
- Ether
- Peptide
- Others
Marine Derived Drugs Market, By Source
- Algae
- Microorganisms
- Invertebrates
Marine Derived Drugs Market, By Application
- Anti-microbial
- Anti-viral
- Anti-inflammatory
- Anti-tumor
- Anti-cardiovascular
- Other
Marine Derived Drugs Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Marine Derived Drugs Market, By Company
- Abbott Laboratories
- BioMarin Pharmaceutical, Inc.
- GlaxoSmithKline Plc
- Marine Polymer Technologies
- Pharma Marine USA
- Genzyme
- Bayer Innovation
- Takeda Oncology’s Millennium
- Xenome Limited
- Pfizer
The report covers:
- Global Marine Derived Drugs market sizes from 2021 to 2028, along with CAGR for 2023-2028
- Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global Marine Derived Drugs market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Marine Derived Drugs market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global Marine Derived Drugs market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Marine Derived Drugs market share. Major industry players with significant revenue share include Abbott Laboratories, BioMarin Pharmaceutical, Inc., GlaxoSmithKline Plc, Marine Polymer Technologies, Pharma Marine USA, Genzyme, Bayer Innovation, Takeda Oncology’s Millennium, Xenome Limited, Pfizer, and others.
Reasons to Buy this Report:
- Gain detailed insights on the Marine Derived Drugs industry trends
- Find complete analysis on the market status
- Identify the Marine Derived Drugs market opportunities and growth segments
- Analyse competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Antibiotics and Antimicrobials Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5. Marine Derived Drugs Market, By Type
5.1 Introduction
5.2 Phenol
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Steroid
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Ether
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Peptide
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Others
5.6.1 Market Overview
5.6.2 Market Size and Forecast
6. Marine Derived Drugs Market, By Source
6.1 Introduction
6.2 Algae
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Microorganisms
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Invertebrates
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. Marine Derived Drugs Market, By Application
7.1 Introduction
7.2 Anti-microbial
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Anti-viral
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Anti-inflammatory
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Anti-tumor
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Anti-cardiovascular
7.6.1 Market Overview
7.6.2 Market Size and Forecast
7.7 Other
7.7.1 Market Overview
7.7.2 Market Size and Forecast
8. Marine Derived Drugs Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Marine Derived Drugs, By Type
8.2.2 North America Marine Derived Drugs, By Source
8.2.3 North America Marine Derived Drugs, By Application
8.3 Europe
8.3.1 Europe Marine Derived Drugs, By Type
8.3.2 Europe Marine Derived Drugs, By Source
8.3.3 Europe Marine Derived Drugs, By Application
8.4 Asia-Pacific
8.4.1 Asia-Pacific Marine Derived Drugs, By Type
8.4.2 Asia-Pacific Marine Derived Drugs, By Source
8.4.3 Asia-Pacific Marine Derived Drugs, By Application
8.5 Rest of the World
8.5.1 Rest of the World Marine Derived Drugs, By Type
8.5.2 Rest of the World Marine Derived Drugs, By Source
8.5.3 Rest of the World Marine Derived Drugs, By Application
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 BioMarin Pharmaceutical, Inc.
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 GlaxoSmithKline Plc
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Marine Polymer Technologies
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Pharma Marine USA
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Genzyme
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Bayer Innovation
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Takeda Oncology’s Millennium
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Xenome Limited
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Pfizer
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Marine Derived Drugs Market has been segmented as below:
Marine Derived Drugs Market, By Type
- Phenol
- Steroid
- Ether
- Peptide
- Others
Marine Derived Drugs Market, By Source
- Algae
- Microorganisms
- Invertebrates
Marine Derived Drugs Market, By Application
- Anti-microbial
- Anti-viral
- Anti-inflammatory
- Anti-tumor
- Anti-cardiovascular
- Other
Marine Derived Drugs Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Marine Derived Drugs Market, By Company
- Abbott Laboratories
- BioMarin Pharmaceutical, Inc.
- GlaxoSmithKline Plc
- Marine Polymer Technologies
- Pharma Marine USA
- Genzyme
- Bayer Innovation
- Takeda Oncology’s Millennium
- Xenome Limited
- Pfizer
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of Marine Derived Drugs Market?
The market is expected to grow at a CAGR of 9.1% during the study period (2023-2028)
How big is the Marine Derived Drugs Market value?
The Global Marine Derived Drugs Market is expected to be around US$ 3565 Million by 2028
What is the segment’s covered for the Marine Derived Drugs Market?
The segment included in the Marine Derived Drugs Market is Type, Source, Application, Company and region.
Who are the major key vendors in the Marine Derived Drugs Market?
Some key players operating in the Marine Derived Drugs Market include Abbott Laboratories, BioMarin Pharmaceutical, Inc., GlaxoSmithKline Plc, Marine Polymer Technologies, Pharma Marine USA, Genzyme, Bayer Innovation
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE